top of page
This site was designed with the
.com
website builder. Create your website today.Start Now

PUBLICATIONS

Books 

  1. Khan A.A. (2012) Bacteria and Cancer, Springer Science Publisher, The Netherlands (Click to Read Book Review)

  2. Jain S.K., Khan A.A., Rai M.K. (2010) Geomicrobiology, Science Publisher, Taylors & Francis Group. CRC Press 

  3. Ashraf M.T., Khan A.A., Aldakheel M.F. (2023) Systems Biology approaches to understand host-pathogen interactions, Elsevier (In Press)

Edited Journal Issues​​

  1. Host-pathogen interactions interplay and cancer: understanding mechanisms and beyond (2023) Front Oncology (Impact factor 5.738) (Click here)

  2. Microbiome in the growth and management of different types of cancer (2023) Front Mol Biosci (Impact factor 5) (Click here),

  3. Currently Editing: Advances and Challenges in Understanding Microbial Pathogenesis through Systems Biology and Artificial Intelligence (2023) Diagnostics (Impact factor 3.6) (Click here)

Journal Articles (Impact Factors - Clarivate Analytics JCR 2022, Cumulative Impact factor ~350) 
First &/or *Corresponding author publications

  1. Banerjee A., Dass D., Dhotre K., Wakchoure P., More A., Rana S., Khan A.A.*, Mukherjee A. (2023) Combinatorial Effects of miRNAs in HSV-2 Infection of Macrophages: An In Silico and In Vitro Integration Approach. Vaccines, 11, 1488. (https://doi.org/10.3390/vaccines11091488) [Impact factor 7.8] (Co-corresponding author)

  2. Wakchoure P., Momin K., Khan A.A.* (2023) Pathogenesis of Human Immunodeficiency Virus and Mycobacterium tuberculosis Infection as Revealed by Transcriptome and Interactome Data. OMICS: A Journal of Integrative Biology, 27(1):15-23. (http://doi.org/10.1089/omi.2022.0130) [Impact factor 3.978] (Corresponding author)

  3. Khan AA, Büsselberg D, de Oliveira GLV and Khan S (2023) Editorial: Microbiome in the growth and management of different types of cancer. Front. Mol. Biosci. 10:1249301. doi: 10.3389/fmolb.2023.1249301 [Impact factor 5] (First author)

  4. *Khan A.A. & Ahmad E. (2023)   Editorial: Host-Pathogen Interactions Interplay and Cancer: Understanding Mechanisms and Beyond. Frontiers in Oncology [Impact factor 5.738] (First & Corresponding author)

  5. *Khan A.A., Nema V., Ashraf T. (2023) Host-microbiota interactions and Oncogenesis: crosstalk and its implications in etiology. Microbial Pathogenesis (https://doi.org/10.1016/j.micpath.2023.106063) [Impact factor 3.848] (First & Corresponding author)

  6. *Khan A.A., Jain S.K., Rai M., Panda S. (2022) Exploring SARS-CoV2 host-pathogen interactions and associated fungal infections cross-talk: screening of targets and understanding pathogenesis. Comp Struct Biotech J (https://doi.org/10.1016/j.csbj.2022.08.013) [Impact factor 6.155] (First & Corresponding author) 

  7. *Khan A.A., Ashraf M.T., Aldakheel F.M., Yazgan A.S., Zaidi R . (2022) Deciphering the involvement of iron targets in colorectal cancer: A network biology approach. Am J Trans Res 14(1):440-451 [Impact factor 3.940] (First & Corresponding author) 

  8. *Khan A.A., Khan Z. (2021) Comparative host-pathogen protein-protein interactions analysis of recent coronavirus outbreaks and important host targets identification. Briefings in Bioinformatics (https://doi.org/10.1093/bib/bbaa207) (Impact factor 13.994) (First & Corresponding author)

  9. *Khan A.A., Khan Z. (2021) Bacterial Nucleomodulins and Cancer: An unresolved enigma (https://doi.org/10.1016/j.tranon.2020.100922) Trans Oncol (Impact factor 4.803) (First & Corresponding author)

  10. *Khan A.A. (2021) Exploring polyps to colon carcinoma voyage: can blocking the crossroad halt the sequence? (doi: 10.1007/s00432-021-03685-5) J Cancer Res Clin Oncol (Impact factor 4.322) (Sole author)

  11. *Khan A.A., Bano Y. (2021) Salmonella enterica subsp. enterica host-pathogen interactions and their implications in gallbladder cancer. Microbial Pathogenesis (https://doi.org/10.1016/j.micpath.2021.105011) (Impact factor 3.848) (First & Corresponding author) 

  12. *Khan A.A., Sirsat A.T., Singh H., Cash P. (2021) Microbiota and cancer: current understanding and mechanistic implications. Clin Trans Oncol (doi: 10.1007/s12094-021-02690-x) [Impact factor 3.340] (First & Corresponding author)  

  13. *Khan A.A., Farooq F., Jain S.K., Golinska P., Rai M. (2021) Comparative host-pathogen interaction analyses of SARS-CoV2 and Aspergillus fumigatus, and pathogenesis of COVID-19 associated aspergillosis. Microbial Ecology (https://doi.org/10.1007/s00248-021-01913-6 ) [Impact factor 4.192] (First & Corresponding author) 

  14. *Khan A.A., Singh H., Bilal M., Ashraf M.T. (2021) Microbiota, probiotics and respiratory infections: the three musketeers can tip off potential management of COVID-19. Am J Transl Res (http://www.ajtr.org/files/ajtr0136096.pdf ) [Impact factor 3.940] (First & Corresponding author)

  15. *Khan A.A., Khan Z. (2020) COVID-2019 associated over-expressed Prevotella proteins mediated host-pathogen interactions and their role in coronavirus outbreak. Bioinformatics (doi: 10.1093/bioinformatics/btaa285) (Impact factor 6.931) (First & Corresponding author) 

  16. *Khan A.A., Abuderman A.A., Ashraf M.T., Khan Z. (2020) Protein-protein interactions of Human papilloma virus-Chlamydia trachomatis-Human and their potential in cervical cancer. Future Microbiology (doi: https://doi.org/10.2217/fmb-2019-0242) (Impact factor 3.553) (First & Corresponding author)

  17. *Khan A.A., Nema V., Khan Z. (2020) Current status of probiotics for prevention and management of gastrointestinal cancers (https://doi.org/10.1080/14712598.2021.1828858) Exp Opin Biol Ther (Impact factor 5.589) (First & Corresponding author)

  18. *Khan A.A. and Khan Z. (2020) System biological investigations of Hydroxychloroquine and Azithromycin targets and their implications in QT interval prolongation (https://doi.org/10.1016/j.cbi.2020.109299)  Chem Biol Interaction (Impact factor 5.168) (First & Corresponding author)

  19. *Khan A.A., Khan Z., Malik A., Kalam M.A., Cash P. Alshamsan A. (2017) Colorectal cancer-inflammatory bowel disease nexus and felony of Escherichia coli. Life Sci (doi: https://doi.org/10.1016/j.lfs.2017.05.016) (Impact factor: 6.780) (First & Corresponding author)

  20. *Khan A.A., Khan Z., Kalam M.A., Khan A.A. (2016) Inter-kingdom prediction certainty evaluation of protein subcellular localization tools: microbial pathogenesis approach for deciphering host microbe interaction. Briefings in Bioinformatics (doi: 10.1093/bib/bbw093) (Impact factor 13.994) (First & Corresponding author)

  21. *Khan A.A., Khan Z., Warnakulasuriya S. (2016) Cancer-associated toll-like receptor modulation and insinuation in infection susceptibility: association or coincidence? Ann Oncol (doi: 10.1093/annonc/mdw053) (Impact factor 51.769) (First & Corresponding author). 

  22. ¶Shrivastava A., *¶Khan A.A., Khurshid M., Kalam M., Jain S.K., Singhal P.K. (2016) Recent developments in the field of L-asparaginase discovery: a potential anticancer agent [¶Equal Contribution] Critical Reviews in Oncology/Hematology (¶Both are first author) (doi:10.1016/j.critrevonc.2015.01.002) (Impact factor 6.625) (First & Corresponding author) (Top cited journal article)

  23. Khan, Z.*, Khan A.A.*, Yadav H., Prasad, G.B.K.S., Bisen P.S. (2017) Survivin, a molecular target for therapeutic interventions in squamous cell carcinoma. Cell Mol Biol Lett 22: 8. (doi:10.1186/s11658-017-0038-0) (Impact factor 8.702) (Co-first author)

  24. *Khan A.A., Khan Z., Malik A., Khan S., Shrivastava A., Jain S.K., Alshamsan A. (2015) Computational prediction of E. coli proteins host subcellular targeting and their implications in colorectal cancer etiology. Cancer Letters (doi: http://dx.doi.org/10.1016/j.canlet.2015.04.024) (Impact factor 9.756) (First & Corresponding author).

  25. *Khan A.A. (2014) In silico prediction of E. coli proteins targeting the host cell nucleus, with special reference to their role in colon cancer etiology. J Comp Biol (DOI:10.1089/cmb.2014.0001) (Impact factor 1.549) (Sole author).

  26. *Khan A.A., Cash P. (2013) E. coli and colon cancer: Is mutY a culprit? Cancer Letters 341(2): 127-131 (Impact factor 9.756) (First & Corresponding author)

  27. *Khan A.A., Khurshid M., Khan S., AlShamsan A. (2013) Gut microbiota and probiotics: Current status and their role in cancer therapeutics. Drug Dev. Res. (DOI 10.1002/ddr.21087) (Impact factor 5.004) [Invited article as subject expert] (First & Corresponding author)

  28. Khan A.A., Khurshid M., Tawfik A.F. (2013) In vitro evaluation of vincristine and fluconazole combination against Candida spp. Pak J Pharm Sci 26(5): 1037-1040 (Impact factor 0.863)

  29. *Khan A.A., Shrivastava A., Khurshid M. (2012) Normal to cancer microbiome transformation and its implication in cancer diagnosis. BBA Rev. Cancer 1826(2): 331-337 (Impact factor 11.414) (First & Corresponding author)

  30. *Khan A.A. and Shrivastava A. (2010) Bacterial infection associated with cancer: Possible implication in etiology with special reference to lateral gene transfer. Cancer Metastasis Rev. 29(2): 331-337 (Impact factor 9.237) (First & Corresponding author)

  31. *Khan A.A. (2010). Intracellular mechanism of Apoptosis. J. Biol. Sci. 10(4):291-305

  32. *Khan A.A., Jain S.K., Shrivastav A. (2008) Prevalence of dental caries among the population of Gwalior (India) in relation of different associated factors, Eur. J. Dent. 2: 81-85 (First & Corresponding author)

As Co-Author

  1. Shyamveer, Khan A.A., Singh, HO. Effect of genetic variations in drug transporters, metabolizing enzyme and regulatory genes to the development of HIV-associated lipodystrophy. J Gene Med. 2023;e3493. Accepted Author Manuscript. https://doi.org/10.1002/jgm.3493 (Impact factor: 4.152)

  2. Shibata T., Cao D.-Y., Dar T.B., Ahmed F., Bhat S.A., Veiras L.C., Bernstein E.A., Khan A.A., Chaum M., Shiao S.L., Tourtellotte W.G., Giani J.F., Bernstein K.E., Cui X., Vail E., Khan Z. (2022) miR766-3p and miR124-3p Dictate Drug Resistance and Clinical Out-come in HNSCC. Cancers 14, x. https://doi.org/10.3390/cancers14215273 (Impact factor 6.575) 

  3. Ahmed, F.; Khan, A.A.; Ansari, H.R.; Haque, A. A (2022) Systems Biology and LASSO-Based Approach to Decipher the Transcriptome–Interactome Signature for Predicting Non-Small Cell Lung Cancer. Biology, 11, 1752. https://doi.org/10.3390/biology11121752 (Impact factor: 5.168)

  4. ​Yang X., Siddiqui A., Khan A.A., Wang Q., Malik A., Jan A.T., Rudyani H.A., Chaudhary A.A., Khan S. (2021) Chlamydia trachomatis infection: Their potential implications in the etiology of cervical cancer. J Cancer (doi:10.7150/jca.58582) (Impact factor 4.478) 

  5. Singh H., Jadhav S., Khan A.A., Agrawal S.K., Choudhari R., Verma S., Agrawal S., Gupta V., Singh A., Nain S., Maan H.S. (2021) APOBEC3, TRIM5α, and BST2 polymorphisms in healthy individuals of various populations with special references to its impact on HIV transmission, Microbial Path (https://doi.org/10.1016/j.micpath.2021.105326) (Impact factor 3.848).

  6. Singh H., Choudhari R., Khan A.A. (2021) Immune mediating molecules and pathogenesis of COVID-19-associated neurological disease. Microbial Path. (doi: 10.1016/j.micpath.2021.105023) (Impact factor 3.848)

  7. Singh H., Choudhari R., Nema V., Khan A.A. (2020) ACE2 and TMPRSS2 polymorphisms in various diseases with special reference to its impact on COVID-19 disease. Microbial Path. (DOI: https://doi.org/10.1016/j.micpath.2020.104621) (Impact factor 3.848)

  8. Bagheri A.R., Aramesh N., Khan A.A., Gul I., Ghotekar S., Bilal M. (2020) Molecularly imprinted polymers-based adsorption and photocatalytic approaches for mitigation of environmentally-hazardous pollutants -a review. J Env Chem Eng DOI: https://doi.org/10.1016/j.jece.2020.104879 (Impact factor 7.968) (Article ID 104879)

  9. Afzal M., Mazhar S.F., Sana S., Naeem M., Rasool M.H., Saqalein M., Nisar M.A., Rasool M., Bilal M., Khan A.A., Khurshid M. (2020) Neurological and cognitive significance of probiotics: a holy grail deciding individual personality. Future Microbiol.  DOI: https://doi.org/10.2217/fmb-2019-0143 (Impact factor 3.553)

  10. Munir S., Shah A.A., Rahman H., Bilal M., Rajoka M.S.R., Khan A.A., Khurshid M. (2020) Nanozymes for medical biotechnology and its potential applications in biosensing and nanotherapeutics. Biotechnol Lett DOI: https://doi.org/10.1007/s10529-020-02795-3 (Impact factor: 2.716) 

  11. Bhat M.A., Al-Omar M.A., Naglah A.M., Khan A.A. (2019) Enaminone derived pyrazoles with antimicrobial activity. Journal of Chemistry Article ID 2467970, DOI: https://doi.org/10.1155/2019/2467970 (Impact factor: 3.241)

  12. Alhowyan A.A., Altamimi M.A., Kalam M.A., Khan A.A., Badran M., Binkhathlan Z., Alkholief M., Alshamsan A. (2019) Antifungal efficacy of Itraconazole loaded PLGA-nanoparticles stabilized by Vitamin-E TPGS: In vitro and ex vivo studies. J Microbiol Methods. pii: S0167-7012(18)30984-9. doi: 10.1016/j.mimet.2019.01.020. (Impact factor: 2.622)

  13. Kalam M.A., Khan A.A., Alshamsan A., Haque A., Shakeel F. (2018) Solubility of a poorly soluble immunosuppressant in different pure solvents: Measurement, correlation, thermodynamics and molecular interactions. J Mol Liquids (DOI: 10.1016/j.molliq.2017.11.028) (Impact factor 6.633)

  14. Kalam M.A., Khan A.A., Alshamsan A. (2017) Biodegradable polymeric nanoparticles and vesicular carriers for vaccine delivery via non-invasive routes of administration: A review. Am J Transl Res, 9(1):15-35 (Impact factor 3.940)

  15. Bhat M.A., Khan A.A., Al-Omar M.A., Khan A.A. (2017) Synthesis and anti-Candidal activity of some new pyrazoline derivatives. Biomed Res 28 (7): 3082-3087 

  16. Khan A.A., Jabeen M., Alanazi A., Khan A.A. (2016) Antifungal efficacy of amphotericin B encapsulated fibrin microsphere for treating Cryptococcus neoformans infection in Swiss albino mice. Brazilian J Infec Dis (doi: 10.1016/j.bjid.2016.04.006) (Impact factor 3.257)

  17. Malik A., Kumar D., Khan A.A., Khan, A.A., Chaudhary A.A., Husain S.A., Kar P. (2016) Hepatitis B virus precore G1896A mutation in chronic liver disease patients with HBeAg negative serology from North India. Saudi J Biol Sci (doi:10.1016/j.sjbs.2016.05.004) (Impact factor 4.052).

  18. Khan S., Imran A., Khan A.A., Kalam M.A., Alshamsan A. (2016) Systems biology approaches for the prediction of possible role of Chlamydia pneumoniae proteins in the etiology of lung cancer. PLOS One (doi: 10.1371/journal.pone.0148530) (Impact factor 3.752)

  19. Kalam M.A., Khan A.A., Khan S., AlMalik A., Alshamsan A. (2016) Optimizing Indomethacin-loaded Chitosan nanoparticle size, encapsulation, and release using Box-Behnken experimental design. Int J biol macromol 87:329-340 (Impact factor 8.025). 

  20. Khan S., Ansari A.A., Khan A.A., Ahmad R. (2016) In vitro evaluation of anticancer and biological activities of synthesized Manganese oxide nanoparticles. Med Chem Comm (doi:  10.1039/C6MD00219F) (Impact factor 5.121)

  21. Khan S., Ansari A.A., Khan A.A.,  Al-Kattan W., Al-Obaid O., Ahmad R. (2016) Design, synthesis and in-vitro evaluation of anticancer and antibacterial potential of surface modified Tb(OH)3@SiO2 core-shell nanoparticles. RSC Advances 6: 18667-18677 (Impact factor 4.036).

  22. Bhat M.A., Khan A.A., Ghabbour H.A., Quah C.K., Fun H.K. (2016) Synthesis, characterization, X-ray structure and antimicrobial activity of N-(4-Chlorophenyl)-2-(pyridin-4-ylcarbonyl) hydrazinecarbothioamide. Trop J Pharm Res 15 (8): 1751-1757 (Impact factor 0.523) 

  23. Khan Z., Khan A.A., Prasad G.B.K.S., Khan N., Tiwari R.P., Bisen P.K. (2016) Growth inhibition and chemo-radiosensitization of head and neck squamous cell carcinoma (HNSCC) by Survivin-siRNA Lentivirus. Radiotherapy and Oncology 118(2):359-68 (Impact factor 6.901).

  24. Khurshid M., Akbar R., Nisar M.A., Rahman H., Aslam B., Khan A.A., Rasool M.H. (2015) Bacterial munch for infants: potential pediatric therapeutic interventions of probiotics. Future Microbiology 10(11):1881-95. (Impact factor 3.553)

  25. Khan S., Ansari A.A., Khan A.A., Ahmad R., Al-Obaid O., Al-Kattan W. (2015) In vitro evaluation of anticancer and antibacterial activities of cobalt oxide nanoparticles. J Biol Inorg Chem. 20(8):1319-26. (doi: 10.1007/s00775-015-1310-2) (Impact factor 3.862)

  26. Muhammad S., Khurshid M., Saleem H.G., Khan A.A. (2015) Characteristic and antibiotic resistance of urinary tract pathogens in Punjab. Jundishapur J Microbiol 8(7): e19272. (doi: 10.5812/jjm.19272v2) (Impact factor 0.820)

  27. Bhat M., Khan A.A., Khan S., Abdl Aziz H.A., Alanazi A.M., Al-Omar M.A. (2014) Synthesis of new [1,2,4]triazolo[3,4-b][1,3,4]thiadiazines and study of their anti-Candidal and cytotoxic activities. J Chem, Article ID 897141 (Impact factor 3.241)

  28. Bhat M., Khan A.A., Khan S., Al-Omar M.A., Parvez M.K., Al Dosari M.S. (2014) Synthesis and anti-Candida activity of N- (4-aryl/cyclohexyl) -2-(pyridine-4-yl carbonyl) hydrazinecarbothioamide. Bioorg Med Chem Letters  (DOI:10.1016/j.bmcl.2014.01.060) (Impact factor 2.940)

  29. Farooq F., Rai M., Tiwari A., Khan A.A., Farooq S. (2012) Medicinal potential of Moringa oleifera: An overview of promising healer. J. Med. Plant. Res. 6 (27): 4368-4374 

  30. Shrivastava A., Khan A.A., Shrivastav A., Jain S.K., Singhal P.K. (2012) Kinetic study of purified L-asparaginase from Penicillium sp. Prep. Biochem. Biotech. 42: 574-581 (Impact factor 3.141)

  31. Shrivastava A., Khan A.A., Jain S.K., Singhal P.K., Jain S., Marotta F., Yadav H. (2010) Biotechnological advancement in isolation of anti-neoplastic compounds from natural origin: a novel source of L-asparaginase. Acta Biomedica 81(2):104-108

  32. Bhatnagar P., Khan A.A., Jain M. Kaushik S. & Jain S.K. (2007). Microbiological study of khoa sold in chambal region (Madhya Pradesh): A case study. Indian J. Microbiol. 47(3): 263-266 (Impact factor 2.461)

  33. Bhatnagar P., Khan A.A., Jain M. & Jain S.K. Shrivastav A. (2007). Bacteriological study of khoa sold in Gwalior & Morena city (Madhya Pradesh) in relation to public health. Asian J. Exp. Sci. 21(1): 55-62

  34. Jain M., Khan A.A., Gupta A., Pandey M., Bhatnagar P., Jain S.K. (2008) An epidemic of typhoid fever in a hostel, Indian J. Field Vet. 4(1):46-47   

  35. Khan A.A., Shrivastava A. Jain S.K. (2009) In vitro susceptibility of antibiotics against pathogenic bacteria, BIOZONE Int. J. Life Sci. 1(1): 24-27

Book Chapters

  1. Jha S., Khan A.A., Ashraf M.T. (2019) Designing of Artificial Metalloenzymes. In: Husain Q., Ullah M. (eds) Biocatalysis. Springer, Cham DOI https://doi.org/10.1007/978-3-030-25023-2_9

  2. Khan A.A., Khan S. (2015) “Probiotics and cancer”. Encyclopedia of Cancer (Ed) Manfred Schwab, Springer

  3. Shrivastava A., Khan A.A., Jain S.K., Singhal P.K. (2012) Bacterial asparaginase: A potential therapeutic agent for leukemia. ”Bacteria and Cancer (Ed) Abdul Arif Khan, Springer Science Publisher, Netherlands

  4. Bhatnagar P, Khan A.A., Jain S.K. and Rai M.K. (2010) "Biodeterioration of archaeological monuments: An approach for restoration". Geomicrobiology (Ed) Sudhir K. Jain, A. Arif Khan, M.K. Rai, Science Publisher, CRC Press, USA

  5. *Khan A.A., Bhatnagar P., Jain S.K.,  Deshmukh S.K., Rai M.K. (2006) “Recent methods for fungal community analysis with special reference to TGGE and DGGE”. Current Advances in Fungal Biotechnology" (Ed.) M. K. Rai Publisher- I. K. International Pvt Ltd. New Delhi, pp. 450-462

Magazine Articles

  1. Sharma E., Rochlani D., *Khan A.A. (2011) Automated liver function test: An important advancement in rapid testing of liver function. Med Equipments & Automation Oct 2011, pp. 55-57

  2. *Khan A.A. (2010) Automated antibacterial susceptibility testing in clinical laboratories. Med Equipments & Automation May-June 2010: pp. 44-47

  3. Khan A.R., Farooq F., *Khan A.A. (2010) Clinical microbiology laboratory automation: A Way towards improving clinical microbiology diagnosis. Med Equipments & Automation Nov-Dec 2010: pp. 76-80

Web resources developed

  1. Ansari H.R., Ahmed F., Haque A., Khan A.A. (2022) NSCLCPred (https://hifzuransari.shinyapps.io/NSCLCpred/)

  2. Jha S., Ashraf M.T., Khan A.A., Ahmad S. (2016) “Algae Scan” http://www.algaescan.org/index.aspx

  3. Shankar V., Khan A.A. (2009) “Herpes Web” http://herpes.page.tl/

Abstracts

  1. Khan A.A., Shrivastava A., Jain S.K. (2018) Prevalance of Dental caries and effects of dietary habits: understanding effects of oral acid-base balance published in abstract book of 5th International Virtual Science Congress.

  2. Khan A.A. (2014) “E. coli and colon cancer: Who is the culprit?” published in abstract book of 3rd TM World Cancer Conference, USA 

  3. Khan A.A. (2012) “Normal to Cancer Microbiome transformation: Giving clue for cancer detection” published in abstract book of 2nd TM World Cancer Conference, USA 

  4. Khan A.A. (2012) “Bacteriology and Cancer: An old association revisited” published in abstract book of 1st international conference on Biosciences and Bioengineering: A collaborative approach, India

  5. Khan A.A. and Shrivastava A. (2009) “Medical waste disposal system: An integral part of hospital” published in abstract book National seminar on Recent Advances in Environmental Sciences, organized by PG Department of Life Sciences, IASCA, ITM Universe, Gwalior (M.P.)

  6. Khan A.A. (2006) Phylogenetic Analysis of Teeth Decaying Oral Bacteria through CLUSTAL W” published in Abstract book of 4th Annual Rocky Mountain Bioinformatics conference, Colorado USA

  7. Khan A.A., Jain M., Shrivastav A., Jain S.K. (2006) “Bacterial infections jeopardizing patients to cancer” published in Abstract book 47th AMI conference, Bhopal

  8. Bhatnagar P., Mishra A., Khan A.A., Shrivastav A., Jain S.K. (2006) “TGGE & DGGE: An approach for molecular study of microbial community” published in Abstract book 47th AMI conference, Bhopal

  9. Khan A.A. and Shrivastava A. (2004) “Effects of leaf extracts on the growth of E. coli” published in M.P. Science Congress, Indian science congress association, Bhopal chapter

bottom of page